Chimerix Q2 2024 GAAP EPS $(0.23), Inline, Sales $129.000K Beat $62.500K Estimate
Author: Benzinga Newsdesk | August 13, 2024 07:05am
Chimerix (NASDAQ:
CMRX) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $129.000 thousand which beat the analyst consensus estimate of $62.500 thousand by 106.40 percent. This is a 396.15 percent increase over sales of $26.000 thousand the same period last year.
Posted In: CMRX